Armed with some of the world’s most advanced instrumentation, researchers at PNNL are working to analyze huge amounts of data and uncover hidden biological connections.

Three PNNL researchers will receive five continuous years of funding for projects through highly competitive DOE Early Career Research Program awards.

New research sheds light on the biomolecular dangers of night shift work.

PNNL contributes to a nationwide research consortium investigating the molecular mechanisms triggered by endurance training.

Scientists have learned more about how drug resistance develops in patients with acute myeloid leukemia and how the process might be slowed.

A streamlined informatics workflow that automatically processes complex data and provides the locations of double bonds in lipids.

Hi-C metagenomics-informed phage-host infection networks detected in soil pre- and post-drying.

Metabolomics analysis revealed differences in metabolome profiles for two distinct modes of fungal wood decay.

A detailed snapshot of proteins by PNNL scientists marks a big step toward a diagnostic blood test for a deadly form of liver disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Data from increasingly complex mass spectrometry instruments met with adaptable data analysis solution.

Governor Inslee announced the appointment of Karin Rodland to the Board of Directors of the Andy Hill Cancer Research Endowment Fund.

Kristin Burnum-Johnson presented at two virtual events in June on proteome mapping.

Twelve researchers from PNNL presented at the 2020 Metabolomics Association of North America virtual conference in mid-September. Their presentations included a plenary talk, keynote talks, oral presentations, posters, and a lightning talk.